📊 Analyst Consensus & Targets
- Analyst Rating: Buy
- Price Target: $114.375
- Sector: Healthcare – Diagnostics & Research
💡 The Growth Thesis
Buy Consensus: Revvity, Inc. Analysts project a 18.2% potential upside. Currently trading at a Forward P/E of 18.247486.